Our development team has the specialist knowledge, experience and technology to translate COVID-19 immunoassays onto custom microfluidic devices. Our inhouse bioscience team are experts in assessing and characterising existing or novel benchtop assays for commercial product feasibility. Our product development, engineering and manufacturing teams combine to provide a true design-for-manufacture approach that is ISO 13485 certified and ready for scalable mass production.

Developing and manufacture of successful molecular based microfluidic devices presents a unique set of challenges including amplification, contamination control, reagent management, test throughput and cost-of-goods to name a few. Managing these challenges requires a truly integrated team of bio-scientists, product designers and manufacturing engineers all specialised in microfluidics. That’s SCHOTT MINIFAB.

Our high precision moulding, bonding, assembly and logistics capabilities can help you secure supply and increase production volumes of critical polymer consumables for diagnostic platforms and lifescience research use. Whether it be development of custom components or manufacture of existing consumable designs under licence, we are ready to partner with you. Our manufacturing lines are scalable from pilot line quantities up to fully automated lights out throughput.

With SCHOTT Nexterion® we can provide an extensive range of glass substrates and functional coatings for DNA, protein and cell applications. In addition, we also provide products to meet special customer requirements for unique formats, materials, coatings and markings.